Moreover, the ratio of CSF adiponectin to serum adiponectin is directly correlated with the CSF albumin to serum albumin ratio, which identifies the polypeptide protein as a potential marker of BBB damage and disease severity in patients with MS. This evidence concerns the gene ADIPOQ and myeloid sarcoma.